BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 12174898)

  • 21. Genistein represses telomerase activity via both transcriptional and posttranslational mechanisms in human prostate cancer cells.
    Jagadeesh S; Kyo S; Banerjee PP
    Cancer Res; 2006 Feb; 66(4):2107-15. PubMed ID: 16489011
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulation of telomerase and its hTERT messenger in colorectal cancer.
    Boldrini L; Faviana P; Gisfredi S; Donati V; Zucconi Y; Ursino S; Simi P; Baldinotti F; Berti P; Galleri D; Materazzi G; Basolo F; Miccoli P; Pingitore R; Fontanini G
    Oncol Rep; 2004 Feb; 11(2):395-400. PubMed ID: 14719074
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of human telomerase reverse transcriptase gene and protein, and of estrogen and progesterone receptors, in breast tumors: preliminary data from neo-adjuvant chemotherapy.
    Kammori M; Izumiyama N; Hashimoto M; Nakamura K; Okano T; Kurabayashi R; Naoki H; Honma N; Ogawa T; Kaminishi M; Takubo K
    Int J Oncol; 2005 Nov; 27(5):1257-63. PubMed ID: 16211220
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mad1 suppresses bladder cancer cell proliferation by inhibiting human telomerase reverse transcriptase transcription and telomerase activity.
    Zou L; Zhang P; Luo C; Tu Z
    Urology; 2006 Jun; 67(6):1335-40. PubMed ID: 16765199
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Wild-type p16INK4a suppresses cell growth, telomerase activity and DNA repair in human breast cancer MCF-7 cells.
    Duan J; Chen Z; Liu P; Zhang Z; Tong T
    Int J Oncol; 2004 Jun; 24(6):1597-605. PubMed ID: 15138605
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A chromosome 3-encoded repressor of the human telomerase reverse transcriptase (hTERT) gene controls the state of hTERT chromatin.
    Szutorisz H; Lingner J; Cuthbert AP; Trott DA; Newbold RF; Nabholz M
    Cancer Res; 2003 Feb; 63(3):689-95. PubMed ID: 12566315
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Upstream stimulatory factor (USF) as a transcriptional suppressor of human telomerase reverse transcriptase (hTERT) in oral cancer cells.
    Chang JT; Yang HT; Wang TC; Cheng AJ
    Mol Carcinog; 2005 Nov; 44(3):183-92. PubMed ID: 16010690
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlation between radiation-induced telomerase activity and human telomerase reverse transcriptase mRNA expression in HeLa cells.
    Satra M; Tsougos I; Papanikolaou V; Theodorou K; Kappas C; Tsezou A
    Int J Radiat Biol; 2006 Jun; 82(6):401-9. PubMed ID: 16846975
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Down-regulation and growth inhibitory role of C/EBPalpha in breast cancer.
    Gery S; Tanosaki S; Bose S; Bose N; Vadgama J; Koeffler HP
    Clin Cancer Res; 2005 May; 11(9):3184-90. PubMed ID: 15867211
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Doxorubicin modulates telomerase activity in Ewing's sarcoma in vitro and in vivo.
    Lanvers-Kaminsky C; Winter B; Koling S; Frodermann B; Braun Y; Schaefer KL; Diallo R; Koenemann S; Wai D; Willich N; Poremba C; Schuck A
    Oncol Rep; 2005 Sep; 14(3):751-8. PubMed ID: 16077987
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential expression of full-length telomerase reverse transcriptase mRNA and telomerase activity between normal and malignant renal tissues.
    Fan Y; Liu Z; Fang X; Ge Z; Ge N; Jia Y; Sun P; Lou F; Björkholm M; Gruber A; Ekman P; Xu D
    Clin Cancer Res; 2005 Jun; 11(12):4331-7. PubMed ID: 15958614
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Deregulation of estrogen induced telomerase activity in tamoxifen-resistant breast cancer cells.
    Park WC; Liu H; Macgregor Schafer J; Jordan VC
    Int J Oncol; 2005 Nov; 27(5):1459-66. PubMed ID: 16211243
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of human telomerase reverse transcriptase by nonsteroidal antiinflammatory drugs in colon carcinoma.
    He H; Xia HH; Wang JD; Gu Q; Lin MC; Zou B; Lam SK; Chan AO; Yuen MF; Kung HF; Wong BC
    Cancer; 2006 Mar; 106(6):1243-9. PubMed ID: 16444744
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Introduction of p16INK4a inhibits telomerase activity through transcriptional suppression of human telomerase reverse transcriptase expression in human gliomas.
    Saito M; Nakagawa K; Hamada K; Hirose S; Harada H; Kohno S; Nagato S; Ohnishi T
    Int J Oncol; 2004 May; 24(5):1213-20. PubMed ID: 15067344
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Regulation of telomerase activity and cell cycle of K562 cells by oridonin].
    Li RF; Wang QD
    Yao Xue Xue Bao; 2004 Nov; 39(11):865-8. PubMed ID: 15696923
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantitative and spatial measurements of telomerase reverse transcriptase expression within normal and malignant human breast tissues.
    Hines WC; Fajardo AM; Joste NE; Bisoffi M; Griffith JK
    Mol Cancer Res; 2005 Sep; 3(9):503-9. PubMed ID: 16179497
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Leptin upregulates telomerase activity and transcription of human telomerase reverse transcriptase in MCF-7 breast cancer cells.
    Ren H; Zhao T; Wang X; Gao C; Wang J; Yu M; Hao J
    Biochem Biophys Res Commun; 2010 Mar; 394(1):59-63. PubMed ID: 20171193
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of telomerase activity and human telomerase reverse transcriptase gene expression by histone deacetylase inhibitor in human brain cancer cells.
    Khaw AK; Silasudjana M; Banerjee B; Suzuki M; Baskar R; Hande MP
    Mutat Res; 2007 Dec; 625(1-2):134-44. PubMed ID: 17669439
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A study on selective killing effect of Hsv-tk/GCV driven by human telomerase catalytic subunit promoter on human lung cancer cell A549].
    Tang XJ; Wang YP; Zhou QH; Che GW; Chen XH; Zhu DX
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Apr; 24(2):148-52. PubMed ID: 17407070
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of hTERT in apoptosis of cervical cancer induced by histone deacetylase inhibitor.
    Wu P; Meng L; Wang H; Zhou J; Xu G; Wang S; Xi L; Chen G; Wang B; Zhu T; Lu Y; Ma D
    Biochem Biophys Res Commun; 2005 Sep; 335(1):36-44. PubMed ID: 16051188
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.